生物制剂时代银屑病关节炎门诊患者皮肤、肌肉骨骼及心理社会因素对生活质量的影响:横断面研究
该横断面研究纳入131例生物制剂时代门诊银屑病关节炎(PsA)患者,评估皮肤、肌肉骨骼表现及心理社会因素对健康相关生活质量(HRQoL)的影响。调整分析显示,未就业、疲劳、睡眠障碍、焦虑抑郁、mHAQ评分高及合并症与较低15D评分(HRQoL受损)独立相关,而PASI和DLQI无此关联;年轻年龄、较高PsA疾病活动度评分和PASI评分与较高DLQI评分(皮肤生活质量受损)独立相关。结论强调心理社会负担、躯体功能受损和合并症对PsA患者HRQoL的负面影响。
要点
- 心理社会负担(疲劳、睡眠障碍、焦虑抑郁)与PsA患者HRQoL受损独立相关。
- 躯体功能受损(mHAQ评分高)和合并症也与较低HRQoL独立相关。
- 皮肤严重程度(PASI)和皮肤生活质量(DLQI)未独立关联整体HRQoL。
核心结论
- 心理社会负担、躯体功能受损和合并症对PsA门诊患者HRQoL有负面影响。
- 改善PsA患者HRQoL需同时关注心理和躯体问题。
研究设计与样本
- 横断面研究,纳入131例门诊PsA患者,评估人口学、皮肤和肌肉骨骼疾病活动度、患者报告结局、治疗及心理社会负担。
主要发现
- 平均年龄51.9岁,PsA病程8.6年,50.4%为男性,56.9%在职,47.7%有≥1种合并症。
- 单用csDMARDs者36.6%,单用生物制剂者12.2%,两者联用者22.9%。
- 平均DLQI为3.3,平均15D为0.84。
- 调整分析中,未就业、疲劳、睡眠障碍、焦虑抑郁、mHAQ评分高及合并症与较低15D评分独立相关。
- PASI和DLQI未与较低15D评分独立相关;年轻年龄、较高PsA疾病活动度评分和PASI评分与较高DLQI评分独立相关。
临床怎么用
- 评估PsA患者HRQoL时需关注心理社会因素、躯体功能和合并症,而非仅皮肤和关节活动度。
- 改善HRQoL的干预应同时针对心理和躯体问题。
局限性
- 横断面设计无法推断因果关系。
- 样本来自单中心门诊,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In psoriatic arthritis (PsA), both psoriasis and musculoskeletal manifestations may impair Health-Related Quality of Life (HRQoL). Our objective was to explore the impact of the various disease manifestations and disease consequences, including psychosocial factors, on HRQoL in PsA patients treated in the biologic treatment era. METHODS: Data collection in the 131 outpatient clinic PsA patients assessed included demographics, disease activity measures for both skin and musculoskeletal involvement and patient-reported outcome (PRO) measures, treatment and psychosocial burden. The skin dimension of quality of life was assessed by the Dermatology Life Quality Index (DLQI) and the overall HRQoL by the 15-Dimensional (15D) Questionnaire. RESULTS: The mean age was 51.9 years, PsA disease duration 8.6 years, 50.4% were men, 56.9% were employed/working and 47.7% had ≥1 comorbidities. Prevalence of monotherapy with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) was 36.6% and with biologic DMARDs 12.2% and combination of both 22.9%. Mean DLQI was 3.3 and 15D 0.84. In adjusted analysis, not employed/working, higher scores for fatigue, sleep disturbances, anxiety and depression, Modified Health Assessment Questionnaire and presence of comorbidities were independently associated with impaired HRQoL (lower 15D scores), whereas Psoriasis Area Severity Index (PASI) and DLQI were not. Younger age and higher Psoriatic Arthritis Disease Activity Score and PASI scores were independently associated with impaired skin quality of life (higher DLQI score). CONCLUSION: Our study highlights the negative impact the psychosocial burden, impaired physical function and comorbidities has on reduced HRQoL in PsA outpatients. Thus, to further improve HRQoL in PsA patients, not only physical concerns but also psychological concerns need to be addressed.
引用
- Haugeberg G, Michelsen B, Kavanaugh A, et al. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open. 2020. PMID: 32409518. doi:10.1136/rmdopen-2020-001223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。